Get started Log in

KRON — Kronos Bio Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
$53.65m
Enterprise Value
-$46.08m
Revenue
$9.85m

Brief: Kronos Bio Reports Q1 Loss Per Share $0.48
11/05/2021 21:50
Brief: Kronos Bio Posts Qtrly Loss Per Share $0.70
23/03/2021 21:10
Brief: Kronos Bio Announces Positive End-Of-Phase 2 Meeting With FDA For Entospletinib In Newly Diagnosed Npm1-Mutated Acute Myeloid Leukemia
04/03/2021 12:12
Brief: Kronos Bio Announces First Patient Dosed In Phase 1/2 Clinical Trial Of KB-0742, An Oral CDK9 Inhibitor Targeting MYC-Amplified Cancers
25/02/2021 14:41
Brief: Kronos Bio Appoints Marianne De Backer, Ph.D., To Board Of Directors
26/01/2021 13:49
Brief: Kronos Bio Announces FDA Clearance Of IND Application For KB-0742
07/12/2020 13:08
Brief: Kronos Bio Reports Q3 Loss Per Share $6.48
18/11/2020 13:12
Brief: Kronos Bio Inc Says Kb-0742 Reduced Tumor Growth In Castration-Resistant Prostate Cancer
22/10/2020 13:08
U.S. STOCKS ON THE MOVE-GE, eBay, Mallinckrodt, VivoPower International, Kronos Bio, Vontier
09/10/2020 18:55
Kronos Bio Inc: Soars 50% in Nasdaq debut
09/10/2020 17:08
Brief: Kronos Bio Shares Open About 50% Above IPO Price In Nasdaq Debut
09/10/2020 17:07
NASDAQ RESUMED AT 11:58 AM
09/10/2020 16:58
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:02 AM
09/10/2020 09:02
Brief: Kronos Says Pricing Of IPO Of 13,157,895 Shares At $19.00 Per Share
09/10/2020 01:12